Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Lung Cancer(2019)

引用 17|浏览45
暂无评分
摘要
•DLL3 is considered as Trojan horse for potent therapeutic implication.•An important heterogeneity of CTCs was demonstrated in patients with SCLC.•Changes of DLL3+ CTCs on treatment seem to be of prognostic importance.
更多
查看译文
关键词
DLL3,Vimentin,SCLC,CTCs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要